{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:27:57Z","timestamp":1781076477224,"version":"3.54.1"},"reference-count":20,"publisher":"European Respiratory Society (ERS)","issue":"6","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2018,11,24]]},"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1183\/13993003.02180-2018","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T15:45:32Z","timestamp":1545320732000},"page":"1802180","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["New short regimens for latent tuberculosis treatment: safety first!"],"prefix":"10.1183","volume":"52","author":[{"given":"Dick","family":"Menzies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anete","family":"Trajman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"2024101910061764000_52.6.1802180.1","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva, World Health Organization, 2018. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531235\/ Date last accessed: November 23, 2018."},{"key":"2024101910061764000_52.6.1802180.2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031912-114431"},{"key":"2024101910061764000_52.6.1802180.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30216-X"},{"key":"2024101910061764000_52.6.1802180.4","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","volume":"2","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2024101910061764000_52.6.1802180.5","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1972.106.3.357"},{"key":"2024101910061764000_52.6.1802180.6","first-page":"3617408","article-title":"Acute and fatal isoniazid-induced hepatotoxicity: a case report and review of the literature","volume":"2016","author":"Kabbara","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"2024101910061764000_52.6.1802180.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/147.5.1311"},{"key":"2024101910061764000_52.6.1802180.8","first-page":"735","article-title":"Update: adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection \u2013 United States, 2003","volume":"52","author":"Centers for Disease Control and Prevention (CDC), American Thoracic Society","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024101910061764000_52.6.1802180.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104875"},{"key":"2024101910061764000_52.6.1802180.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005136"},{"key":"2024101910061764000_52.6.1802180.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714283"},{"key":"2024101910061764000_52.6.1802180.12","doi-asserted-by":"publisher","DOI":"10.1157\/13102264"},{"key":"2024101910061764000_52.6.1802180.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714284"},{"key":"2024101910061764000_52.6.1802180.14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-10-200811180-00003"},{"key":"2024101910061764000_52.6.1802180.15","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1019"},{"key":"2024101910061764000_52.6.1802180.16","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.6.1712"},{"key":"2024101910061764000_52.6.1802180.17","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.17.1863"},{"key":"2024101910061764000_52.6.1802180.18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2024101910061764000_52.6.1802180.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01470-2018"},{"key":"2024101910061764000_52.6.1802180.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02180-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:33:03Z","timestamp":1740382383000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02180-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,12,20]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1183\/13993003.02180-2018"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02180-2018","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}